(Q45354150)

English

A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.

scientific article published on 22 October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maurizio Federico

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Maurizio Federico

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

22 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

7229-7237

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23099330%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Exosomes: extracellular organelles important in intercellular communication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Exosomes: immune properties and potential clinical implementations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Glycosyl-Phosphatidylinositol-Anchored Interleukin-2 Expressed on Tumor-Derived Exosomes Induces Antitumor Immune Response in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Exosome Display technology: applications to the development of new diagnostics and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Increasing vaccine potency through exosome antigen targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Mechanisms of HIV-1 Nef function and intracellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

The Nef protein of HIV-1 associates with rafts and primes T cells for activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Nef increases infectivity of HIV via lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Massive Secretion by T Cells Is Caused by HIV Nef in Infected Cells and by Nef Transfer to Bystander Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

The stoichiometry of Gag protein in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Cellular internalization of exosomes occurs through phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

New protocol for lentiviral vector mass production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Production and characterization of clinical grade exosomes derived from dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.010

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45354150&oldid=1369032230"